Live cell imaging market: In-depth analysis

Live Cell Imaging is a technique that uses time-lapse microscopy to optically analyze living cells throughout time. Cells can thus be watched over long periods in order to visualize extremely slow activities that are below the limits of human vision. Live cell imaging investigations are commonly used to study cell migration, fertilization, cell development, wound healing, and differentiation processes. The live cell imaging market worth in 2021 was $1.95 billion, and by 2030 it will reach $4.18 billion, growing at a CAGR of 8.8% during 2021-2030.

Market drivers

The rising prevalence of chronic diseases such as neurodegeneration, cancer, and cardiovascular disease is likely to drive the worldwide live cell imaging market throughout the forecast period. The increased prevalence of chronic diseases and the related requirement for quick diagnostic tools are driving up demand for live-cell imaging.  During the projected period, the worldwide live-cell imaging market is expected to grow due to an increase in the development and implementation of live-cell imaging systems. For example, CytoSMART Technologies announced the release of a new live-cell imaging system in May 2020. The CytoSMART Lux2 Duo Kit provides a simple, cost-effective method for researchers to perform instantaneous side-by-side comparisons of cell cultures.

Market restraints

high content screening systems are expensive due to their complex functions. A confocal microscope, for example, costs more than $250,000, and a wide-field microscope costs more than $100,000. As a result of the greater costs of these systems, it is becoming increasingly difficult for ordinary people to afford them, hampering the overall market growth.

Market opportunities

Brazil, China, India, and Russia are developing participants in the live-cell imaging market, with potential opportunities for live-cell image systems due to increasing R&D activity for various firms in these countries. According to a National Bureau of Statistics analysis, China’s overall R&D expenditure in 2021 will be over 2.79 trillion yuan (about $441.13 billion), up 14.2% yearly.

Market segmentation

  • On the basis of product, the live cell imaging market is segmented into consumables, equipment, and software.
  • The equipment segment held a significant position in the overall market in 2020 owing to the rising usage of instruments for evaluating, recording, and gaining insights related to cell operations. Microscopes, cell analyzers, image capture systems, and standalone systems are all part of the instruments segment. The ongoing technological innovation that is leading to the development of unique microscopes is pushing the adoption of equipment even further. The consumable segment will have the largest CAGR in the next years, owing to the increasing demand for consumables in live-cell image, which results in repeated purchases.

  • In terms of Application, the live cell imaging market is segmented into developmental biology, cell biology, and stem cell & drug discovery.
  • Cell biology ruled the overall live-cell imaging market because of the research and development done on molecular interaction networks. Live-cell imaging is required for a wide number of cell biologists and cell-based investigations in order to comprehend the elemental cellular structures as well as their interaction at the tissue level. This method provides improved clarity of structural components and natural variability, thus propelling its use in cell biology research.

  • On the basis of technology, the live cell imaging market is segmented into fluorescence resonance energy transfer, timelapse microscopy, fluorescence recovery after photobleaching, and high content screening.
  • The fluorescence resonance energy transfer segment held a dominant position in the overall live-cell imaging market due to its advantages in determining the spatial proximity of protein levels. Furthermore, this technology became popular in recent decades due to the increase in the Application of genetic peptides.

  • Regionally, the live cell imaging market is segmented into Europe, Europe, Asia Pacific, and LAMEA.
  • As of 2020, North America has the largest industry share. The significant position of this region’s market is due to a larger patient pool and a rising senior population. The significant investment and financing available for live-cell imagings research are one of the region’s primary drivers. The United States has the biggest market in North America due to factors such as a growing number of R&D programs in the country and an increasing number of chronic illnesses.

    Also read-

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    WC Captcha 8 × = eight